Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Her doctor and several pharmacies turned her down because she was below the recommended…
Automation can reduce manual labor, standardize documentation quality, strengthen payer accountability, and give leaders the data visibility to make confident decisions under tight time constraints. The post The Behavioral Health Workforce Crisis: Administrative Burden Is Breaking Your Nursing Team appeared first on MedCity News.
Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore. The post UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China appeared first on MedCity News.
Lisa Mazur, J.D., head of strategy for law firm McDermott Will & Schulte’s healthcare practice, discusses developments around chatbots, algorithmic fairness, and prior authorization
Legislation passed by the Energy and Commerce Committee could increase the number of people without health insurance by 8.6 million, due largely to changes to Medicaid and the ACA. Combining the provisions with the effect of the expected expiration of the ACA’s enhanced premium tax credits, CBO expects 13.7 million more people will be uninsured…
Elli Lilly has been in the news lately because of the announced $1 billion investment in a joint innovation lab with Nvidia, an AI powerhouse player. But AI drug discovery is only part of the story of where AI can be leveraged in biopharma. The post Lilly’s Chief Information & Digital Officer: AI Use Goes…
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like Blue Shield of California and Evernorth have undergone CEO exits. There were also layoffs at organizations including HHS, Blue Cross of Idaho and the University…
Novartis is paying $120 million up front to secure rights to a Monte Rosa molecular glue degrader drug candidate as well as options for two others. The two companies began working together last year under an alliance focused on immune mediated-diseases. The post Novartis Adds to Its Immunology Prospects With Another Deal for Monte Rosa’s…
This brief examines recent state trends in Medicaid behavioral health coverage and payment and state coverage of select treatment models for people with serious mental illness—a population that has historically faced significant barriers to care. This includes details about coverage of Certified Community Behavioral Health Clinics (CCBHCs) (as a provider type), Assertive Community Treatment (ACT),…
Startup has expanded its Care+ home visits across lines of business to Medicare, Medicaid and Marketplace